CAS: 139308-65-9 - Tolafentrine
Formula:C28H31N3O4S
InChI:InChI=1/C28H31N3O4S/c1-18-5-11-21(12-6-18)36(32,33)30-20-9-7-19(8-10-20)28-23-16-27(35-4)26(34-3)15-22(23)24-17-31(2)14-13-25(24)29-28/h5-12,15-16,24-25,30H,13-14,17H2,1-4H3/t24-,25-/m0/s1
- Sinonimi:
- rel-(-)-N-[4-[(4aR,10bS)-1,2,3,4,4a,10b-Hexahydro-8,9-dimethoxy-2-methylbenzo[c][1,6]naphthyridin-6-yl]phenyl]-4-methylbenzenesulfonamide
- N-{4-[(4aS,10bR)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin-6-yl]phenyl}-4-methylbenzenesulfonamide
Benzenesulfonamide, N-[4-[(4aR,10bS)-1,2,3,4,4a,10b-hexahydro-8,9-dimethoxy-2-methylbenzo[c][1,6]naphthyridin-6-yl]phenyl]-4-methyl-, rel-(-)-
CAS:139308-65-9
Formula:
C28H31N3O4S
Colore e forma:
Solid
Peso molecolare:
505.6284
Ref: IN-DA001AQ2
Dimensione non definita | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 10 Dicembre 2024
Ref: 4Z-T-137001
10mg | Prezzo su richiesta | ||
25mg | Prezzo su richiesta | ||
50mg | Prezzo su richiesta | ||
100mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 10 Dicembre 2024
Tolafentrine
Prodotto ControllatoCAS:139308-65-9
Applications A dual-selective phosphodiesterase 3/4 inhibitor used in chronic experimental pulmonary hypertension. References Huxtable, R., …
Formula:
C28H31N3O4S
Colore e forma:
Neat
Peso molecolare:
505.63
Ref: TR-T531000
2mg | 872,00 € | ||
5mg | 1.784,00 € | ||
500µg | 268,00 € |
Consegna stimata in Stati Uniti, il Martedì 17 Dicembre 2024
Tolafentrine
CAS:139308-65-9
Tolafentrine is a drug used to treat chronic bronchitis and inflammatory bowel disease. It is …
Formula:
C28H31N3O4S
Purezza:
Min. 98 Area-%
Colore e forma:
Powder
Peso molecolare:
505.63 g/mol
Ref: 3D-FT28303
1mg | 986,00 € | ||
2mg | 1.392,00 € | ||
5mg | 2.551,00 € | ||
10mg | 4.637,00 € | ||
500µg | 582,00 € |
Consegna stimata in Stati Uniti, il Martedì 21 Gennaio 2025